Article(id=1329835351625019974, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329835237376373459, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2024.01.005, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1677513600000, receivedDateStr=2023-02-28, revisedDate=1694275200000, revisedDateStr=2023-09-10, acceptedDate=null, acceptedDateStr=null, onlineDate=1794987054972, onlineDateStr=2026-11-18, pubDate=1704816000000, pubDateStr=2024-01-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794987054972, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794987054972, creator=13701087609, updateTime=1794987054972, updator=13701087609, issue=Issue{id=1329835237376373459, tenantId=1146029695717560320, journalId=1319690329412173987, year='2024', volume='45', issue='1', pageStart='1', pageEnd='102', issueExtLink='null', onlineDate='null', pubDate='1704816000000', pubDateStr='2024-01-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794987027734, creator='13701087609', updateTime=1794988176831, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329840057474724591, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329835237376373459, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329840057478918896, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329835237376373459, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=26, endPage=31, ext={EN=ArticleExt(id=1329835351910232647, articleId=1329835351625019974, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Value of nabuliumab combined with ipilimumab in the treatment of locally advanced lung adenocarcinoma, columnId=1325221089055486019, journalTitle=World Clinical Drug, columnName=Article, runingTitle=null, highlight=null, articleAbstract=
Objective

To evaluate the efficacy and safety of nabuliumab combined with ipilimumab in the first-line treatment of locally advanced lung adenocarcinoma.

Methods

Ninety-two patients with locally advanced lung adenocarcinoma were randomly divided into control group and combined group by random number table method, 46 cases in each group. The control group received pemetrexed combined with cisplatin, and the combined group received nabuliumab combined with ipilimumab. Disease control rate (DCR), objective response rate (ORR), safety, tumor downstaging rate, major pathological response (MPR), pathological complete response (pCR) rate and tumor markers were compared between the two groups.

Results

The rates of ORR, DCR, tumor downstaging in the combined group were higher than those in the control group (P<0.05), and the incidence of adverse reaction in grade Ⅲ and above was lower than that in the control group (P<0.05). After 2 months of treatment, serum carcino-embryonic antigen (CEA), cytokeratin 19 fragment antigen 21-1 (Cyfra21-1) and neurone-specific enolase (NSE) levels in 2 groups were decreased compared with those before treatment (P<0.05), and serum CEA, Cyfra21-1 and NSE levels in combined group were significantly lower than those in control group (P<0.05).

Conclusion

Nabuliumab combined with ipilimumab in the first-line treatment of locally advanced lung adenocarcinoma can increase ORR, DCR, tumor descending stage rate, and the adverse reactions are controllable.

, authors=Bing YU, Meng ZHANG, Fei GUO, Huiting LI, authorsList=Bing YU, Meng ZHANG, Fei GUO, Huiting LI, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329835352182862408, articleId=1329835351625019974, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=纳武利尤单抗联合伊匹木单抗治疗局部晚期肺腺癌的价值, columnId=1325221089235841093, journalTitle=世界临床药物, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=
目的

探讨纳武利尤单抗联合伊匹木单抗一线治疗局部晚期肺腺癌患者的疗效和安全性。

方法

92例局部晚期肺腺癌患者,随机分为对照组及联合组,每组46例。对照组采用培美曲塞联合顺铂新辅助治疗,联合组采用纳武利尤单抗联合伊匹木单抗新辅助治疗。比较两组疾病控制率(disease control rate,DCR)、客观缓解率(objective response rate,ORR)、安全性以及肿瘤降期率、主要病理缓解(major pathological response,MPR)、完全病理缓解(pathological complete response,pCR)率和肿瘤标志物差异。

结果

联合组ORR、DCR、肿瘤降期率高于对照组(P<0.05),Ⅲ度及以上不良反应率低于对照组(P<0.05)。两组治疗2个月血清癌胚抗原(carcino-embryonic antigen,CEA)、细胞角蛋白19片段抗原21-1(cytokeratin 19 fragment antigen 21-1,Cyfra21-1)、神经元特异性烯醇化酶(neurone-specific enolase,NSE)水平均较治疗前降低(P<0.05),联合组治疗2个月血清CEA、Cyfra21-1及NSE水平明显低于对照组(P<0.05)。

结论

纳武利尤单抗联合伊匹木单抗一线治疗局部晚期肺腺癌可提高ORR、DCR及肿瘤降期率,且不良反应在可控范围内。

, authors=于冰, 张蒙, 郭飞, 李慧婷, authorsList=于冰, 张蒙, 郭飞, 李慧婷, authorCompany=null, correspAuthors=null, authorNote=

于冰,副主任医师,研究方向:肺癌的临床诊治。

, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=SauPAfTYSt/H87esxoMlmw==, magXml=7E5yYD4gLqV/aZ3g/UpMQQ==, pdfUrl=null, pdf=wFXa1+mR3OK5MJOZxivy9w==, pdfFileSize=1636257, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=Fz1HV0JtjYxjwOcss/UM5A==, mapNumber=null, fund=null)}, authors=[Author(id=1329835352468075086, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835352547766864, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, authorId=1329835352468075086, language=EN, stringName=Bing YU, firstName=Bing, middleName=null, lastName=YU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Respiratory and Critical Care Medicine, Yantai Affiliated Hospital of Binzhou Medical University (the Second School of Clinical Medicine of Binzhou Medical University), Binzhou 264100, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835352631652945, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, authorId=1329835352468075086, language=CN, stringName=于冰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=滨州医学院烟台附属医院(滨州医学院第二临床医学院)呼吸与危重症医学科,山东 滨州 264100, bio={"content":"

于冰,副主任医师,研究方向:肺癌的临床诊治。

"}, bioImg=null, bioContent=

于冰,副主任医师,研究方向:肺癌的临床诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835352392577610, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, xref=null, ext=[AuthorCompanyExt(id=1329835352396771915, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, companyId=1329835352392577610, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Respiratory and Critical Care Medicine, Yantai Affiliated Hospital of Binzhou Medical University (the Second School of Clinical Medicine of Binzhou Medical University), Binzhou 264100, Shandong Province, China), AuthorCompanyExt(id=1329835352405160524, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, companyId=1329835352392577610, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=滨州医学院烟台附属医院(滨州医学院第二临床医学院)呼吸与危重症医学科,山东 滨州 264100)])]), Author(id=1329835352702956115, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835352770064981, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, authorId=1329835352702956115, language=EN, stringName=Meng ZHANG, firstName=Meng, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Respiratory and Critical Care Medicine, Yantai Affiliated Hospital of Binzhou Medical University (the Second School of Clinical Medicine of Binzhou Medical University), Binzhou 264100, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835352845562454, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, authorId=1329835352702956115, language=CN, stringName=张蒙, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=滨州医学院烟台附属医院(滨州医学院第二临床医学院)呼吸与危重症医学科,山东 滨州 264100, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835352392577610, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, xref=null, ext=[AuthorCompanyExt(id=1329835352396771915, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, companyId=1329835352392577610, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Respiratory and Critical Care Medicine, Yantai Affiliated Hospital of Binzhou Medical University (the Second School of Clinical Medicine of Binzhou Medical University), Binzhou 264100, Shandong Province, China), AuthorCompanyExt(id=1329835352405160524, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, companyId=1329835352392577610, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=滨州医学院烟台附属医院(滨州医学院第二临床医学院)呼吸与危重症医学科,山东 滨州 264100)])]), Author(id=1329835352950420056, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835353063666266, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, authorId=1329835352950420056, language=EN, stringName=Fei GUO, firstName=Fei, middleName=null, lastName=GUO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Respiratory and Critical Care Medicine, Yantai Affiliated Hospital of Binzhou Medical University (the Second School of Clinical Medicine of Binzhou Medical University), Binzhou 264100, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835353143358043, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, authorId=1329835352950420056, language=CN, stringName=郭飞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=滨州医学院烟台附属医院(滨州医学院第二临床医学院)呼吸与危重症医学科,山东 滨州 264100, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835352392577610, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, xref=null, ext=[AuthorCompanyExt(id=1329835352396771915, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, companyId=1329835352392577610, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Respiratory and Critical Care Medicine, Yantai Affiliated Hospital of Binzhou Medical University (the Second School of Clinical Medicine of Binzhou Medical University), Binzhou 264100, Shandong Province, China), AuthorCompanyExt(id=1329835352405160524, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, companyId=1329835352392577610, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=滨州医学院烟台附属医院(滨州医学院第二临床医学院)呼吸与危重症医学科,山东 滨州 264100)])]), Author(id=1329835353235632733, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835353315324511, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, authorId=1329835353235632733, language=EN, stringName=Huiting LI, firstName=Huiting, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Respiratory and Critical Care Medicine, Yantai Affiliated Hospital of Binzhou Medical University (the Second School of Clinical Medicine of Binzhou Medical University), Binzhou 264100, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835353386627680, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, authorId=1329835353235632733, language=CN, stringName=李慧婷, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=滨州医学院烟台附属医院(滨州医学院第二临床医学院)呼吸与危重症医学科,山东 滨州 264100, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835352392577610, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, xref=null, ext=[AuthorCompanyExt(id=1329835352396771915, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, companyId=1329835352392577610, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Respiratory and Critical Care Medicine, Yantai Affiliated Hospital of Binzhou Medical University (the Second School of Clinical Medicine of Binzhou Medical University), Binzhou 264100, Shandong Province, China), AuthorCompanyExt(id=1329835352405160524, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, companyId=1329835352392577610, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=滨州医学院烟台附属医院(滨州医学院第二临床医学院)呼吸与危重症医学科,山东 滨州 264100)])])], keywords=[Keyword(id=1329835353499873889, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, language=EN, orderNo=1, keyword=nivolumab), Keyword(id=1329835353575371362, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, language=EN, orderNo=2, keyword=ipilimumab), Keyword(id=1329835353646674531, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, language=EN, orderNo=3, keyword=locally advanced lung adenocarcinoma), Keyword(id=1329835353709589092, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, language=EN, orderNo=4, keyword=immunotherapy), Keyword(id=1329835353785086565, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, language=CN, orderNo=1, keyword=纳武利尤单抗), Keyword(id=1329835353868972646, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, language=CN, orderNo=2, keyword=伊匹木单抗), Keyword(id=1329835353931887207, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, language=CN, orderNo=3, keyword=局部晚期肺腺癌), Keyword(id=1329835353998996072, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, language=CN, orderNo=4, keyword=免疫治疗)], refs=[Reference(id=1329835354200322666, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Song J, Sun Y, Cao H, et al. A novel pyroptosis-related lncRNA signature for prognostic prediction in patients with lung adenocarcinoma[J]. Bioengineered, 2021, 12(1): 5932-5949., articleTitle=null, refAbstract=null), Reference(id=1329835354275820139, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=虞思来, 倪建佼, 朱正飞. 免疫治疗时代不可手术局部晚期非小细胞肺癌的治疗: 现状与展望[J]. 中国癌症杂志, 2022, 32(6): 487-498., articleTitle=null, refAbstract=null), Reference(id=1329835354363900524, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Peters S, Scherpereel A, Cornelissen R, et al. First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743[J]. Ann Oncol, 2022, 33(5): 488-499., articleTitle=null, refAbstract=null), Reference(id=1329835354439397997, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Wolchok JD, Chiarion-Sileni V, Gonzalez R, et al. Long-term outcomes with nivolumab plus ipilimumab or nivolumab alone versus ipilimumab in patients with advanced melanoma[J]. J Clin Oncol, 2022, 40(2): 127-137., articleTitle=null, refAbstract=null), Reference(id=1329835354544255598, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Overman MJ, Lonardi S, Wong KYM, et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer[J]. J Clin Oncol, 2018, 36(8): 773-779., articleTitle=null, refAbstract=null), Reference(id=1329835354649113199, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Postow MA, Chesney J, Pavlick AC, et al. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma[J]. N Engl J Med, 2015, 372(21): 2006-2017., articleTitle=null, refAbstract=null), Reference(id=1329835354728804976, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=杨龙海, 叶波, 魏星, 等. 最新国际肺癌TNM分期标准(第8版)修订稿解读[J]. 中国医刊, 2016, 51(9): 22-25., articleTitle=null, refAbstract=null), Reference(id=1329835354787525233, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Eisenhauerae A, Therasseb P, Bogaerts J, et al. New response evaluation criteria in solid tumors: revised RECIST guideline (version1.1)[J]. Eur J Cancer, 2009, 45(2): 228-247., articleTitle=null, refAbstract=null), Reference(id=1329835354846245490, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=World Health Organization. WHO handbook for reporting results of cancer treatment[R]. Geneva, 1980., articleTitle=null, refAbstract=null), Reference(id=1329835354917548659, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Denisenko TV, Budkevich IN, Zhivotovsky B. Cell death-based treatment of lung adenocarcinoma[J]. Cell Death Dis, 2018, 9(2): 117., articleTitle=null, refAbstract=null), Reference(id=1329835354993046132, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Wang Q, Li M, Yang M, et al. Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy[J]. Aging (Albany NY), 2020, 12(4): 3312-3339., articleTitle=null, refAbstract=null), Reference(id=1329835355123069557, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=孙雪林, 周磊, 胡欣. PD-1抑制剂纳武利尤单抗的药理作用与临床评价[J]. 中国新药杂志, 2019, 28(12): 1445-1449., articleTitle=null, refAbstract=null), Reference(id=1329835355253092982, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Camacho LH. CTLA-4 blockade with ipilimumab: biology, safety, efficacy, and future considerations[J]. Cancer Med, 2015, 4(5): 661-672., articleTitle=null, refAbstract=null), Reference(id=1329835355336979064, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Hodi FS, Chesney J, Pavlick AC, et al. Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial[J]. Lancet Oncol, 2016, 17(11): 1558-1568., articleTitle=null, refAbstract=null), Reference(id=1329835355458613881, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Rotte A. Combination of CTLA-4 and PD-1 blockers for treatment of cancer[J]. J Exp Clin Cancer Res, 2019, 38(1): 255., articleTitle=null, refAbstract=null), Reference(id=1329835355605414522, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Hellmann MD, Rizvi NA, Goldman JW, et al. Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study[J]. Lancet Oncol, 2017, 18(1): 31-41., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329835354099659369, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, awardId=2019WS0140, language=CN, fundingSource=山东省医药卫生科技发展计划项目(2019WS0140), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329835352392577610, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, xref=null, ext=[AuthorCompanyExt(id=1329835352396771915, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, companyId=1329835352392577610, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Respiratory and Critical Care Medicine, Yantai Affiliated Hospital of Binzhou Medical University (the Second School of Clinical Medicine of Binzhou Medical University), Binzhou 264100, Shandong Province, China), AuthorCompanyExt(id=1329835352405160524, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, companyId=1329835352392577610, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=滨州医学院烟台附属医院(滨州医学院第二临床医学院)呼吸与危重症医学科,山东 滨州 264100)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.01.005, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.01.005, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2024.01.005, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2024.01.005, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1704816000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
纳武利尤单抗联合伊匹木单抗治疗局部晚期肺腺癌的价值
于冰 , 张蒙 , 郭飞 , 李慧婷
世界临床药物 | 研究论文 2024,45(1): 26-31
收起
收藏切换
世界临床药物 |研究论文 2024 , 45 (1) : 26 -31
纳武利尤单抗联合伊匹木单抗治疗局部晚期肺腺癌的价值
全屏
[Author(id=1329835352468075086, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835352547766864, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, authorId=1329835352468075086, language=EN, stringName=Bing YU, firstName=Bing, middleName=null, lastName=YU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Respiratory and Critical Care Medicine, Yantai Affiliated Hospital of Binzhou Medical University (the Second School of Clinical Medicine of Binzhou Medical University), Binzhou 264100, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835352631652945, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, authorId=1329835352468075086, language=CN, stringName=于冰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=滨州医学院烟台附属医院(滨州医学院第二临床医学院)呼吸与危重症医学科,山东 滨州 264100, bio={"content":"

于冰,副主任医师,研究方向:肺癌的临床诊治。

"}, bioImg=null, bioContent=

于冰,副主任医师,研究方向:肺癌的临床诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835352392577610, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, xref=null, ext=[AuthorCompanyExt(id=1329835352396771915, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, companyId=1329835352392577610, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Respiratory and Critical Care Medicine, Yantai Affiliated Hospital of Binzhou Medical University (the Second School of Clinical Medicine of Binzhou Medical University), Binzhou 264100, Shandong Province, China), AuthorCompanyExt(id=1329835352405160524, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, companyId=1329835352392577610, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=滨州医学院烟台附属医院(滨州医学院第二临床医学院)呼吸与危重症医学科,山东 滨州 264100)])]), Author(id=1329835352702956115, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835352770064981, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, authorId=1329835352702956115, language=EN, stringName=Meng ZHANG, firstName=Meng, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Respiratory and Critical Care Medicine, Yantai Affiliated Hospital of Binzhou Medical University (the Second School of Clinical Medicine of Binzhou Medical University), Binzhou 264100, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835352845562454, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, authorId=1329835352702956115, language=CN, stringName=张蒙, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=滨州医学院烟台附属医院(滨州医学院第二临床医学院)呼吸与危重症医学科,山东 滨州 264100, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835352392577610, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, xref=null, ext=[AuthorCompanyExt(id=1329835352396771915, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, companyId=1329835352392577610, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Respiratory and Critical Care Medicine, Yantai Affiliated Hospital of Binzhou Medical University (the Second School of Clinical Medicine of Binzhou Medical University), Binzhou 264100, Shandong Province, China), AuthorCompanyExt(id=1329835352405160524, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, companyId=1329835352392577610, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=滨州医学院烟台附属医院(滨州医学院第二临床医学院)呼吸与危重症医学科,山东 滨州 264100)])]), Author(id=1329835352950420056, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835353063666266, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, authorId=1329835352950420056, language=EN, stringName=Fei GUO, firstName=Fei, middleName=null, lastName=GUO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Respiratory and Critical Care Medicine, Yantai Affiliated Hospital of Binzhou Medical University (the Second School of Clinical Medicine of Binzhou Medical University), Binzhou 264100, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835353143358043, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, authorId=1329835352950420056, language=CN, stringName=郭飞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=滨州医学院烟台附属医院(滨州医学院第二临床医学院)呼吸与危重症医学科,山东 滨州 264100, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835352392577610, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, xref=null, ext=[AuthorCompanyExt(id=1329835352396771915, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, companyId=1329835352392577610, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Respiratory and Critical Care Medicine, Yantai Affiliated Hospital of Binzhou Medical University (the Second School of Clinical Medicine of Binzhou Medical University), Binzhou 264100, Shandong Province, China), AuthorCompanyExt(id=1329835352405160524, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, companyId=1329835352392577610, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=滨州医学院烟台附属医院(滨州医学院第二临床医学院)呼吸与危重症医学科,山东 滨州 264100)])]), Author(id=1329835353235632733, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329835353315324511, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, authorId=1329835353235632733, language=EN, stringName=Huiting LI, firstName=Huiting, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Respiratory and Critical Care Medicine, Yantai Affiliated Hospital of Binzhou Medical University (the Second School of Clinical Medicine of Binzhou Medical University), Binzhou 264100, Shandong Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329835353386627680, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, authorId=1329835353235632733, language=CN, stringName=李慧婷, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=滨州医学院烟台附属医院(滨州医学院第二临床医学院)呼吸与危重症医学科,山东 滨州 264100, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329835352392577610, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, xref=null, ext=[AuthorCompanyExt(id=1329835352396771915, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, companyId=1329835352392577610, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Respiratory and Critical Care Medicine, Yantai Affiliated Hospital of Binzhou Medical University (the Second School of Clinical Medicine of Binzhou Medical University), Binzhou 264100, Shandong Province, China), AuthorCompanyExt(id=1329835352405160524, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329835351625019974, companyId=1329835352392577610, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=滨州医学院烟台附属医院(滨州医学院第二临床医学院)呼吸与危重症医学科,山东 滨州 264100)])])]
于冰, 张蒙, 郭飞, 李慧婷
作者信息
  • 滨州医学院烟台附属医院(滨州医学院第二临床医学院)呼吸与危重症医学科,山东 滨州 264100
作者简介:

于冰,副主任医师,研究方向:肺癌的临床诊治。

Value of nabuliumab combined with ipilimumab in the treatment of locally advanced lung adenocarcinoma
Bing YU, Meng ZHANG, Fei GUO, Huiting LI
Affiliations
  • Department of Respiratory and Critical Care Medicine, Yantai Affiliated Hospital of Binzhou Medical University (the Second School of Clinical Medicine of Binzhou Medical University), Binzhou 264100, Shandong Province, China
出版时间: 2024-01-10 doi: 10.13683/j.wph.2024.01.005
文章导航
收藏切换
目的

探讨纳武利尤单抗联合伊匹木单抗一线治疗局部晚期肺腺癌患者的疗效和安全性。

方法

92例局部晚期肺腺癌患者,随机分为对照组及联合组,每组46例。对照组采用培美曲塞联合顺铂新辅助治疗,联合组采用纳武利尤单抗联合伊匹木单抗新辅助治疗。比较两组疾病控制率(disease control rate,DCR)、客观缓解率(objective response rate,ORR)、安全性以及肿瘤降期率、主要病理缓解(major pathological response,MPR)、完全病理缓解(pathological complete response,pCR)率和肿瘤标志物差异。

结果

联合组ORR、DCR、肿瘤降期率高于对照组(P<0.05),Ⅲ度及以上不良反应率低于对照组(P<0.05)。两组治疗2个月血清癌胚抗原(carcino-embryonic antigen,CEA)、细胞角蛋白19片段抗原21-1(cytokeratin 19 fragment antigen 21-1,Cyfra21-1)、神经元特异性烯醇化酶(neurone-specific enolase,NSE)水平均较治疗前降低(P<0.05),联合组治疗2个月血清CEA、Cyfra21-1及NSE水平明显低于对照组(P<0.05)。

结论

纳武利尤单抗联合伊匹木单抗一线治疗局部晚期肺腺癌可提高ORR、DCR及肿瘤降期率,且不良反应在可控范围内。

纳武利尤单抗  /  伊匹木单抗  /  局部晚期肺腺癌  /  免疫治疗
Objective

To evaluate the efficacy and safety of nabuliumab combined with ipilimumab in the first-line treatment of locally advanced lung adenocarcinoma.

Methods

Ninety-two patients with locally advanced lung adenocarcinoma were randomly divided into control group and combined group by random number table method, 46 cases in each group. The control group received pemetrexed combined with cisplatin, and the combined group received nabuliumab combined with ipilimumab. Disease control rate (DCR), objective response rate (ORR), safety, tumor downstaging rate, major pathological response (MPR), pathological complete response (pCR) rate and tumor markers were compared between the two groups.

Results

The rates of ORR, DCR, tumor downstaging in the combined group were higher than those in the control group (P<0.05), and the incidence of adverse reaction in grade Ⅲ and above was lower than that in the control group (P<0.05). After 2 months of treatment, serum carcino-embryonic antigen (CEA), cytokeratin 19 fragment antigen 21-1 (Cyfra21-1) and neurone-specific enolase (NSE) levels in 2 groups were decreased compared with those before treatment (P<0.05), and serum CEA, Cyfra21-1 and NSE levels in combined group were significantly lower than those in control group (P<0.05).

Conclusion

Nabuliumab combined with ipilimumab in the first-line treatment of locally advanced lung adenocarcinoma can increase ORR, DCR, tumor descending stage rate, and the adverse reactions are controllable.

nivolumab  /  ipilimumab  /  locally advanced lung adenocarcinoma  /  immunotherapy
于冰, 张蒙, 郭飞, 李慧婷. 纳武利尤单抗联合伊匹木单抗治疗局部晚期肺腺癌的价值. 世界临床药物, 2024 , 45 (1) : 26 -31 . DOI: 10.13683/j.wph.2024.01.005
Bing YU, Meng ZHANG, Fei GUO, Huiting LI. Value of nabuliumab combined with ipilimumab in the treatment of locally advanced lung adenocarcinoma[J]. World Clinical Drug, 2024 , 45 (1) : 26 -31 . DOI: 10.13683/j.wph.2024.01.005
  • 山东省医药卫生科技发展计划项目(2019WS0140)
参考文献 引证文献
排序方式:
[1]
Song J, Sun Y, Cao H, et al. A novel pyroptosis-related lncRNA signature for prognostic prediction in patients with lung adenocarcinoma[J]. Bioengineered, 2021, 12(1): 5932-5949.
[2]
虞思来, 倪建佼, 朱正飞. 免疫治疗时代不可手术局部晚期非小细胞肺癌的治疗: 现状与展望[J]. 中国癌症杂志, 2022, 32(6): 487-498.
[3]
Peters S, Scherpereel A, Cornelissen R, et al. First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743[J]. Ann Oncol, 2022, 33(5): 488-499.
[4]
Wolchok JD, Chiarion-Sileni V, Gonzalez R, et al. Long-term outcomes with nivolumab plus ipilimumab or nivolumab alone versus ipilimumab in patients with advanced melanoma[J]. J Clin Oncol, 2022, 40(2): 127-137.
[5]
Overman MJ, Lonardi S, Wong KYM, et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer[J]. J Clin Oncol, 2018, 36(8): 773-779.
[6]
Postow MA, Chesney J, Pavlick AC, et al. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma[J]. N Engl J Med, 2015, 372(21): 2006-2017.
[7]
杨龙海, 叶波, 魏星, 等. 最新国际肺癌TNM分期标准(第8版)修订稿解读[J]. 中国医刊, 2016, 51(9): 22-25.
[8]
Eisenhauerae A, Therasseb P, Bogaerts J, et al. New response evaluation criteria in solid tumors: revised RECIST guideline (version1.1)[J]. Eur J Cancer, 2009, 45(2): 228-247.
[9]
World Health Organization. WHO handbook for reporting results of cancer treatment[R]. Geneva, 1980.
[10]
Denisenko TV, Budkevich IN, Zhivotovsky B. Cell death-based treatment of lung adenocarcinoma[J]. Cell Death Dis, 2018, 9(2): 117.
[11]
Wang Q, Li M, Yang M, et al. Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy[J]. Aging (Albany NY), 2020, 12(4): 3312-3339.
[12]
孙雪林, 周磊, 胡欣. PD-1抑制剂纳武利尤单抗的药理作用与临床评价[J]. 中国新药杂志, 2019, 28(12): 1445-1449.
[13]
Camacho LH. CTLA-4 blockade with ipilimumab: biology, safety, efficacy, and future considerations[J]. Cancer Med, 2015, 4(5): 661-672.
[14]
Hodi FS, Chesney J, Pavlick AC, et al. Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial[J]. Lancet Oncol, 2016, 17(11): 1558-1568.
[15]
Rotte A. Combination of CTLA-4 and PD-1 blockers for treatment of cancer[J]. J Exp Clin Cancer Res, 2019, 38(1): 255.
[16]
Hellmann MD, Rizvi NA, Goldman JW, et al. Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study[J]. Lancet Oncol, 2017, 18(1): 31-41.
2024年第45卷第1期
19
6
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2024.01.005
  • 接收时间:2023-02-28
  • 首发时间:2026-11-18
  • 出版时间:2024-01-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-02-28
  • 修回日期:2023-09-10
基金
山东省医药卫生科技发展计划项目(2019WS0140)
作者信息
    滨州医学院烟台附属医院(滨州医学院第二临床医学院)呼吸与危重症医学科,山东 滨州 264100
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.01.005
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏